United States Genitourinary Drugs Market Research Report Forecast 2017-2021

March 2017 | 123 pages | ID: U2FB5A39D3AEN
S&P Consulting

Abstracts

The United States Genitourinary Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Genitourinary Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Genitourinary Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Astellas
Pfizer
GlaxoSmithKline
Eli Lily
Bayer AG
Merck
Abbott Laboratories
Bristol-Myers Squibb
Genentech

United States Genitourinary Drugs Market: Product Segment Analysis

Sex Hormones
Urologicals
Type 3

United States Genitourinary Drugs Market: Application Segment Analysis

Genitourinary Cancer
Bladder Cancer
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

United States Genitourinary Drugs Market Research Report Forecast 2017-2021

CHAPTER 1 GENITOURINARY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Genitourinary Drugs Market Segmentation by Type
  1.2.1 United States Production Market Share of Genitourinary Drugs by Type in 2015
  1.2.1 Sex Hormones
  1.2.2 Urologicals
  1.2.3 Type
1.3 Genitourinary Drugs Market Segmentation by Application
  1.3.1 Genitourinary Drugs Consumption Market Share by Application in 2015
  1.3.2 Genitourinary Cancer
  1.3.3 Bladder Cancer
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Genitourinary Drugs (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON GENITOURINARY DRUGS INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES GENITOURINARY DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 United States Genitourinary Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 United States Genitourinary Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Genitourinary Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Genitourinary Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Genitourinary Drugs Market Competitive Situation and Trends
  3.5.1 Genitourinary Drugs Market Concentration Rate
  3.5.2 Genitourinary Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES GENITOURINARY DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Genitourinary Drugs Production and Market Share by Type (2012-2017)
4.2 United States Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Genitourinary Drugs Price by Type (2012-2017)
4.4 United States Genitourinary Drugs Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES GENITOURINARY DRUGS MARKET ANALYSIS BY APPLICATION

5.1 United States Genitourinary Drugs Consumption and Market Share by Application (2012-2017)
5.2 United States Genitourinary Drugs Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES GENITOURINARY DRUGS MANUFACTURERS ANALYSIS

6.1 Astellas
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Pfizer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 GlaxoSmithKline
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Eli Lily
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Bayer AG
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Merck
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Abbott Laboratories
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Bristol-Myers Squibb
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Genentech
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 GENITOURINARY DRUGS MANUFACTURING COST ANALYSIS

7.1 Genitourinary Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Genitourinary Drugs

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Genitourinary Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES GENITOURINARY DRUGS MARKET FORECAST (2017-2021)

11.1 United States Genitourinary Drugs Production, Revenue Forecast (2017-2021)
11.2 United States Genitourinary Drugs Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Genitourinary Drugs Production Forecast by Type (2017-2021)
11.4 United States Genitourinary Drugs Consumption Forecast by Application (2017-2021)
11.5 Genitourinary Drugs Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Genitourinary Drugs
Table Classification of Genitourinary Drugs
Figure United States Sales Market Share of Genitourinary Drugs by Type in 2015
Table Application of Genitourinary Drugs
Figure United States Sales Market Share of Genitourinary Drugs by Application in 2015
Figure United States Genitourinary Drugs Sales and Growth Rate (2011-2021)
Figure United States Genitourinary Drugs Revenue and Growth Rate (2011-2021)
Table United States Genitourinary Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Genitourinary Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Genitourinary Drugs Sales Share by Manufacturers
Figure 2016 Genitourinary Drugs Sales Share by Manufacturers
Table United States Genitourinary Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Genitourinary Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Genitourinary Drugs Revenue Share by Manufacturers
Table 2016 United States Genitourinary Drugs Revenue Share by Manufacturers
Table United States Market Genitourinary Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Genitourinary Drugs Average Price of Key Manufacturers in 2015
Figure Genitourinary Drugs Market Share of Top 3 Manufacturers
Figure Genitourinary Drugs Market Share of Top 5 Manufacturers
Table United States Genitourinary Drugs Sales by Type (2012-2017)
Table United States Genitourinary Drugs Sales Share by Type (2012-2017)
Figure United States Genitourinary Drugs Sales Market Share by Type in 2015
Table United States Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
Table United States Genitourinary Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by Type (2012-2017)
Table United States Genitourinary Drugs Price by Type (2012-2017)
Figure United States Genitourinary Drugs Sales Growth Rate by Type (2012-2017)
Table United States Genitourinary Drugs Sales by Application (2012-2017)
Table United States Genitourinary Drugs Sales Market Share by Application (2012-2017)
Figure United States Genitourinary Drugs Sales Market Share by Application in 2015
Table United States Genitourinary Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Genitourinary Drugs Sales Growth Rate by Application (2012-2017)
Table Astellas Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Astellas Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Genitourinary Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Genitourinary Drugs Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Genitourinary Drugs Market Share (2012-2017)
Table Eli Lily Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lily Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lily Genitourinary Drugs Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Genitourinary Drugs Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Genitourinary Drugs Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Genitourinary Drugs Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Genitourinary Drugs Market Share (2012-2017)
Table Genentech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Genitourinary Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Genitourinary Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genitourinary Drugs
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Genitourinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2015
Table Major Buyers of Genitourinary Drugs
Table Distributors/Traders List
Figure United States Genitourinary Drugs Production and Growth Rate Forecast (2017-2021)
Figure United States Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2021)
Table United States Genitourinary Drugs Production Forecast by Type (2017-2021)
Table United States Genitourinary Drugs Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Astellas, Pfizer, GlaxoSmithKline, Eli Lilly, Bayer AG, Merck, Abbott Laboratories, Bristol-Myers Squibb, Genentech, Roche, Amgen, Botex